The 2016 WHO Classification presents a restructuring of medulloblastomas and other embryonal tumors, medulloblastomas, WNT-activated, medulloblastomas, SHH-activated, and embryonal tumors with multilayered rosettes, C19MC-altered [8]. The gene discussed is SHH; the disease is medulloblastoma.